RVNC

Revance Therapeutics Stock Price

27.41
-0.43 (-1.54%)
Upgrade to Real-Time
Regular Market
27.41

Low
22.89

52 Week Range

High
33.83

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.43 -1.54% 27.41 15:48:07
Open Price Low Price High Price Close Price Prev Close
27.33 27.02 27.72 27.84
Bid Price Ask Price Spread News
27.41 27.44 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,661 171,721 $ 27.34 $ 4,695,561 - 22.89 - 33.83
Last Trade Time Type Quantity Stock Price Currency
15:48:07 100 $ 27.41 USD

Period:

Draw Mode:

Revance Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.97B 71.83M 69.05M $ 15.33M $ - -4.85 -5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -69.70k 2.50%

more financials information »

Revance Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVNC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week27.2327.9225.74527.07460,0350.180.66%
1 Month27.1728.51525.74527.17325,8470.240.88%
3 Months30.8233.8325.4528.75385,346-3.41-11.06%
6 Months29.4333.8325.4528.79397,851-2.02-6.86%
1 Year31.2433.8322.8927.54457,425-3.83-12.26%
3 Years24.0034.629.8821.61499,0443.4114.21%
5 Years17.0137.459.8823.10404,20310.4061.14%

Revance Therapeutics Description

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in research and development of aesthetic and therapeutic products.


Your Recent History
NASDAQ
RVNC
Revance Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.